3S – Systematic, Systemic, and Systems Biology and Toxicology

Summary A biological system is more than the sum of its parts – it accomplishes many functions via synergy. Deconstructing the system down to the molecular mechanism level necessitates the complement of reconstructing functions on all levels, i.e., in our conceptualization of biology and its perturbations, our experimental models and computer modelling. Toxicology contains the somewhat arbitrary subclass “systemic toxicities”; however, there is no relevant toxic insult or general disease that is not systemic. At least inflammation and repair are involved that require coordinated signaling mechanisms across the organism. However, the more body components involved, the greater the challenge to recapitulate such toxicities using non-animal models. Here, the shortcomings of current systemic testing and the development of alternative approaches are summarized. We argue that we need a systematic approach to integrating existing knowledge as exemplified by systematic reviews and other evidence-based approaches. Such knowledge can guide us in modelling these systems using bioengineering and virtual computer models, i.e., via systems biology or systems toxicology approaches. Experimental multi-organon-chip and microphysiological systems (MPS) provide a more physiological view of the organism, facilitating more comprehensive coverage of systemic toxicities, i.e., the perturbation on organism level, without using substitute organisms (animals). The next challenge is to establish disease models, i.e., micropathophysiological systems (MPPS), to expand their utility to encompass biomedicine. Combining computational and experimental systems approaches and the challenges of validating them are discussed. The suggested 3S approach promises to leverage 21st century technology and systematic thinking to achieve a paradigm change in studying systemic effects.

[1]  Linda S Birnbaum,et al.  Cancer and developmental exposure to endocrine disruptors. , 2002, Environmental health perspectives.

[2]  R. Tyl,et al.  Critical evaluation of current developmental toxicity testing strategies: a case of babies and their bathwater. , 2011, Birth defects research. Part B, Developmental and reproductive toxicology.

[3]  Bas J Blaauboer,et al.  An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010". , 2011, ALTEX.

[4]  R. Tennant,et al.  Genetically altered mouse models for identifying carcinogens. , 1999, IARC scientific publications.

[5]  J. Haseman,et al.  The role of transgenic mouse models in carcinogen identification. , 2002, Environmental health perspectives.

[6]  Gary R. Mirams,et al.  Systems Toxicology: Real World Applications and Opportunities , 2017, Chemical research in toxicology.

[7]  T. Hartung Look back in anger - what clinical studies tell us about preclinical work. , 2013, ALTEX.

[8]  T. Kennedy Managing the drug discovery/development interface , 1997 .

[9]  J. Kleinjans,et al.  Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model? , 2014, EXCLI journal.

[10]  C L Alden,et al.  A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk , 2011, Veterinary pathology.

[11]  Michael L Shuler,et al.  Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[12]  Ivan Rusyn,et al.  Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis , 2015, Environmental health perspectives.

[13]  Raffaella Corvi,et al.  How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. , 2007, Mutation research.

[14]  Michael Schwarz,et al.  The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. , 2005, Reproductive toxicology.

[15]  T Seidle,et al.  The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes. , 2007, Current pharmaceutical design.

[16]  Jan G. Hengstler,et al.  Highlight report: towards the replacement of in vivo repeated dose systemic toxicity testing , 2011, Archives of Toxicology.

[17]  Thomas Hartung,et al.  Optimisation of the Post-validation Process , 2008, Alternatives to laboratory animals : ATLA.

[18]  Thomas Hartung,et al.  Good cell culture practices &in vitro toxicology. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.

[19]  Raffaella Corvi,et al.  In vitro genotoxicity testing-Can the performance be enhanced? , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  Julie E Goodman,et al.  A primer on systematic reviews in toxicology , 2017, Archives of Toxicology.

[21]  J. Marx Building Better Mouse Models for Studying Cancer , 2003, Science.

[22]  P. Sorger,et al.  Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks , 2012, Cell.

[23]  Martin Paparella,et al.  Uncertainties of testing methods: What do we (want to) know about carcinogenicity? , 2016, ALTEX.

[24]  G. Daston,et al.  Skeletal malformations and variations in developmental toxicity studies: interpretation issues for human risk assessment. , 2007, Birth defects research. Part B, Developmental and reproductive toxicology.

[25]  T. Knudsen,et al.  A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.

[26]  Lester B Lave,et al.  Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity. , 2003, Regulatory toxicology and pharmacology : RTP.

[27]  Bernadette Modell,et al.  March of Dimes: global report on birth defects, the hidden toll of dying and disabled children. , 2005 .

[28]  David M. Reif,et al.  Analysis of the Effects of Cell Stress and Cytotoxicity onIn Vitro Assay Activity Across a Diverse Chemical and Assay Space , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  Thomas Hartung,et al.  Computational Approaches to Chemical Hazard Assessment , 2017, ALTEX.

[30]  S. H. Bennekou,et al.  Adverse outcome pathways: opportunities, limitations and open questions , 2017, Archives of Toxicology.

[31]  Herbert S. Rosenkranz,et al.  Information value of the rodent bioassay , 1988, Nature.

[32]  T. Hartung Toxicology for the twenty-first century , 2009, Nature.

[33]  Robert J Kavlock,et al.  Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms , 2014, Nature Biotechnology.

[34]  Thomas Hartung,et al.  Making big sense from big data in toxicology by read-across. , 2016, ALTEX.

[35]  Thomas Hartung,et al.  Food for thought... on animal tests. , 2008, ALTEX.

[36]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[37]  M. Aardema,et al.  ECVAM prevalidation study on in vitro cell transformation assays: general outline and conclusions of the study. , 2012, Mutation research.

[38]  T Hartung,et al.  Toward an evidence-based toxicology , 2006, Human & experimental toxicology.

[39]  Richard R Rabbit,et al.  How are reproductive toxicity and developmental toxicity addressed in REACH dossiers? , 2011, ALTEX.

[40]  M. Pike,et al.  Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[41]  Susanne Bremer,et al.  Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[42]  B. Ames,et al.  What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database. , 1998, Drug metabolism reviews.

[43]  T. Collins History and evolution of reproductive and developmental toxicology guidelines. , 2006, Current pharmaceutical design.

[44]  Weida Tong,et al.  Toward predictive models for drug-induced liver injury in humans: are we there yet? , 2014, Biomarkers in medicine.

[45]  G. Lahav,et al.  Schedule-dependent interaction between anticancer treatments , 2016, Science.

[46]  C Helma,et al.  Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments. , 2001, Environmental health perspectives.

[47]  Thomas Hartung,et al.  Food for thought... on evidence-based toxicology. , 2009, ALTEX.

[48]  T. Knudsen,et al.  Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity. , 2017, Reproductive toxicology.

[49]  Thomas Hartung,et al.  Utility of the adverse outcome pathway concept in drug development , 2017, Expert opinion on drug metabolism & toxicology.

[50]  Thomas Hartung,et al.  Chemical regulators have overreached , 2009, Nature.

[51]  Ruili Huang,et al.  Development and Validation of a Computational Model for Androgen Receptor Activity , 2016, Chemical research in toxicology.

[52]  L. Smirnova,et al.  Cellular resilience. , 2015, ALTEX.

[53]  Raffaella Corvi,et al.  Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop , 2017, Toxicology in vitro : an international journal published in association with BIBRA.

[54]  N A Brown,et al.  The value of animal teratogenicity testing for predicting human risk. , 1983, Clinical obstetrics and gynecology.

[55]  Jiri Aubrecht,et al.  Validation of Transcriptomics-Based In Vitro Methods. , 2016, Advances in experimental medicine and biology.

[56]  Wout Slob,et al.  A retrospective analysis of the two-generation study: what is the added value of the second generation? , 2007, Reproductive toxicology.

[57]  Ivan Rusyn,et al.  Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups. , 2018, ALTEX.

[58]  H. Kubinyi Drug research: myths, hype and reality , 2003, Nature Reviews Drug Discovery.

[59]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[60]  E. Silbergeld Commentary: The Rôle of Toxicology in Prevention and Precaution , 2005, International journal of occupational medicine and environmental health.

[61]  U. Thorgeirsson,et al.  Chemical carcinogenesis studies in nonhuman primates. , 2008, Basic life sciences.

[62]  Mardas Daneshian,et al.  Consensus report on the future of animal-free systemic toxicity testing. , 2014, ALTEX.

[63]  M E Hurtt,et al.  Proposal for a tiered approach to developmental toxicity testing for veterinary pharmaceutical products for food-producing animals. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[64]  Nancy C. Baker,et al.  Systems Toxicology of Male Reproductive Development: Profiling 774 Chemicals for Molecular Targets and Adverse Outcomes , 2015, Environmental health perspectives.

[65]  D. Mattison Environmental exposures and development , 2010, Current opinion in pediatrics.

[66]  Anne Hersey,et al.  Legacy data sharing to improve drug safety assessment: the eTOX project , 2017, Nature Reviews Drug Discovery.

[67]  I. Shlyakhter,et al.  An empirical examination of factors influencing prediction of carcinogenic hazard across species. , 1995, Regulatory toxicology and pharmacology : RTP.

[68]  Bing Wang,et al.  Concordance of Noncarcinogenic Endpoints in Rodent Chemical Bioassays , 2015, Risk analysis : an official publication of the Society for Risk Analysis.

[69]  D. Freedman,et al.  From Mouse-to-Man: The Quantitative Assessment of Cancer Risks , 1988 .

[70]  Mardas Daneshian,et al.  Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems. , 2018, ALTEX.

[71]  R. Blust,et al.  Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. , 2012, Reproductive toxicology.

[72]  David M. Reif,et al.  Profiling Chemicals Based on Chronic Toxicity Results from the U.S. EPA ToxRef Database , 2008, Environmental health perspectives.

[73]  B. Kholodenko Drug Resistance Resulting from Kinase Dimerization Is Rationalized by Thermodynamic Factors Describing Allosteric Inhibitor Effects. , 2015, Cell reports.

[74]  E Sabbioni,et al.  Cell Transformation Assays as Predictors of Human Carcinogenicity , 1999, Alternatives to laboratory animals : ATLA.

[75]  Wout Slob,et al.  Deriving a Data-Based Interspecies Assessment Factor Using the NOAEL and the Benchmark Dose Approach , 2007, Critical reviews in toxicology.

[76]  Paul Jennings,et al.  Stem cell-derived systems in toxicology assessment. , 2015, Stem cells and development.

[77]  T. Knudsen,et al.  Identification of vascular disruptor compounds by analysis in zebrafish embryos and mouse embryonic endothelial cells. , 2017, Reproductive toxicology.

[78]  T. Luechtefeld,et al.  The Threshold of Toxicological Concern for prenatal developmental toxicity in rats and rabbits , 2017, Regulatory toxicology and pharmacology : RTP.

[79]  I. Cockburn,et al.  The Economics of Reproducibility in Preclinical Research , 2015, PLoS biology.

[80]  Anthony R Scialli,et al.  Thalidomide: the tragedy of birth defects and the effective treatment of disease. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[81]  Daniel P. Russo,et al.  Global Analysis of Publicly Available Safety Data for 9,801 Substances Registered under REACH from 2008–2014 , 2016, ALTEX.

[82]  L. Smirnova,et al.  Rotenone exerts developmental neurotoxicity in a human brain spheroid model , 2018, Toxicology and applied pharmacology.

[83]  Aldert H Piersma,et al.  Validation of the Postimplantation Rat Whole-embryo Culture Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[84]  L. Bernstein,et al.  Target organs in chronic bioassays of 533 chemical carcinogens. , 1991, Environmental health perspectives.

[85]  Angelo Moretto,et al.  A Tiered Approach to Systemic Toxicity Testing for Agricultural Chemical Safety Assessment , 2006, Critical reviews in toxicology.

[86]  B. van Ravenzwaay,et al.  The threshold of toxicological concern for prenatal developmental toxicity. , 2011, Regulatory toxicology and pharmacology : RTP.

[87]  F. K. Ennever,et al.  The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. , 1987, Mutagenesis.

[88]  Francois Busquet,et al.  The need for strategic development of safety sciences. , 2017, ALTEX.

[89]  Robert J Kavlock,et al.  Profiling the reproductive toxicity of chemicals from multigeneration studies in the toxicity reference database. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[90]  U. Gundert-Remy,et al.  Exposure-triggered reproductive toxicity testing under the REACH legislation: a proposal to define significant/relevant exposure. , 2008, Toxicology letters.

[91]  R. Rudel,et al.  Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms , 2018, Environmental research.

[92]  Melvin E Andersen,et al.  The Human Toxome Project , 2015, ALTEX.

[93]  Narsis A Kiani,et al.  Systems Toxicology: Systematic Approach to Predict Toxicity. , 2016, Current pharmaceutical design.

[94]  Nancy C Baker,et al.  Computational Model of Secondary Palate Fusion and Disruption. , 2017, Chemical research in toxicology.

[95]  David Dix,et al.  A Computational Model Predicting Disruption of Blood Vessel Development , 2013, PLoS Comput. Biol..

[96]  T. Hartung Food for thought ... the first ten years. , 2017, ALTEX.

[97]  D. Rall LABORATORY ANIMAL TESTS AND HUMAN CANCER* , 2000, Drug metabolism reviews.

[98]  R. Jilka The Road to Reproducibility in Animal Research , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[99]  Manuel C. Peitsch,et al.  Systems Toxicology: From Basic Research to Risk Assessment , 2014, Chemical research in toxicology.

[100]  Corvi Raffaella,et al.  EURL ECVAM strategy to avoid and reduce animal use in genotoxicity testing , 2013 .

[101]  Mardas Daneshian,et al.  Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk , 2016, Archives of Toxicology.

[102]  Ich Harmonised,et al.  INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED GUIDELINE GENERAL CONSIDERATIONS FOR CLINICAL STUDIES E8(R1) , 2019 .

[103]  M. Belvin,et al.  RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth , 2010, Nature.

[104]  Imran Shah,et al.  Toxicology ontology perspectives. , 2012, ALTEX.

[105]  J. Kleinjans,et al.  Moving Forward in Human Cancer Risk Assessment , 2010, Environmental health perspectives.

[106]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[107]  Aldert H Piersma,et al.  Validation of the Rat Limb Bud Micromass Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[108]  A. Knight,et al.  The future of teratology research is in vitro , 2005 .

[109]  Gina M. Solomon,et al.  Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation , 2015, Environmental health perspectives.

[110]  Bertrand Desprez,et al.  Non-animal methods to predict skin sensitization (II): an assessment of defined approaches** , 2018, Critical reviews in toxicology.

[111]  Thomas Hartung,et al.  Toward a New Toxicology — Evolution or Revolution? , 2008, Alternatives to laboratory animals : ATLA.

[112]  Thomas Hartung,et al.  Opinion versus evidence for the need to move away from animal testing. , 2017, ALTEX.

[113]  F. Oesch,et al.  Interspecies differences in cancer susceptibility and toxicity. , 1999, Drug metabolism reviews.

[114]  Martin Paparella,et al.  International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances. , 2016, ALTEX.

[115]  Thomas Hartung,et al.  Perspectives on In Vitro to In Vivo Extrapolations. , 2017, Applied in vitro toxicology.

[116]  J. French,et al.  The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[117]  Marlene Ågerstrand,et al.  Weight of evidence evaluation and systematic review in EU chemical risk assessment: Foundation is laid but guidance is needed. , 2016, Environment international.

[118]  Jonathan Balcombe,et al.  Animal Carcinogenicity Studies: 2. Obstacles to Extrapolation of Data to Humans , 2006, Alternatives to laboratory animals : ATLA.

[119]  R. Tennant,et al.  Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.

[120]  David B Duignan,et al.  Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective , 2017, Experimental biology and medicine.

[121]  Svetlana V. Ukraintseva,et al.  Cancer in rodents: does it tell us about cancer in humans? , 2005, Nature Reviews Cancer.

[122]  D. Pamies Good Cell Culture Practice for stem cells and stem-cell-derived models , 2017 .

[123]  Mardas Daneshian,et al.  Validation and quality control of replacement alternatives - Current status and future challenges , 2012 .

[124]  Sebastian Hoffmann,et al.  Evidence-based toxicology for the 21st century: opportunities and challenges. , 2013, ALTEX.

[125]  J. Wikswo,et al.  Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology , 2017, Experimental biology and medicine.

[126]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[127]  Bernhard Voelkl,et al.  Reproducibility of preclinical animal research improves with heterogeneity of study samples , 2018, PLoS biology.

[128]  Alexandra Maertens,et al.  Analysis of Public Oral Toxicity Data from REACH Registrations 2008–2014 , 2016, ALTEX.

[129]  George Daston,et al.  Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern. , 2012, Regulatory toxicology and pharmacology : RTP.

[130]  M. Aardema,et al.  Use of Syrian hamster embryo and BALB/c 3T3 cell transformation for assessing the carcinogenic potential of chemicals. , 1999, IARC scientific publications.

[131]  B. van Ravenzwaay,et al.  The threshold of toxicological concern for prenatal developmental toxicity in rabbits and a comparison to TTC values in rats. , 2012, Regulatory toxicology and pharmacology : RTP.

[132]  Zuang Valerie,et al.  Alternative methods for regulatory toxicology – a state-of-the-art review , 2014 .

[133]  Thomas Hartung,et al.  Integrated Testing Strategies (ITS) for safety assessment. , 2015, ALTEX.

[134]  Zhiyuan Gong,et al.  Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models , 2011, Expert opinion on drug metabolism & toxicology.

[135]  Raffaella Corvi,et al.  ECVAM retrospective validation of in vitro micronucleus test (MNT) , 2008, Mutagenesis.

[136]  Gary W Miller,et al.  Improving reproducibility in toxicology. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[137]  T. Hartung Evidence-based toxicology - the toolbox of validation for the 21st century? , 2010, ALTEX.

[138]  W. Thilly Have environmental mutagens caused oncomutations in people? , 2003, Nature Genetics.

[139]  T. Breit,et al.  A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens , 2014, Archives of Toxicology.

[140]  Thomas Hartung,et al.  3D - a new dimension of in vitro research. , 2014, Advanced drug delivery reviews.

[141]  Aldert Piersma,et al.  The Practical Application of Three Validated In Vitro Embryotoxicity Tests , 2006, Alternatives to laboratory animals : ATLA.

[142]  Mardas Daneshian,et al.  Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity. , 2018, ALTEX.

[143]  Michael B Bracken,et al.  Is animal research sufficiently evidence based to be a cornerstone of biomedical research? , 2014, BMJ : British Medical Journal.

[144]  Sebastian Hoffmann,et al.  Food for thought ... on in silico methods in toxicology. , 2009, ALTEX.

[145]  Jonathan Balcombe,et al.  Animal Carcinogenicity Studies: 1. Poor Human Predictivity , 2006, Alternatives to laboratory animals : ATLA.

[146]  Anthony Atala,et al.  Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling. , 2016, Drug discovery today.

[147]  Corvi Raffaella,et al.  Analysis of carcinogenicity testing for regulatory purposes in the European Union , 2016 .

[148]  T. Hartung Food for thought ... on validation. , 2007, ALTEX.

[149]  Sangeeta Khare,et al.  Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. , 2015, ALTEX.

[150]  Thomas Hartung,et al.  Food for thought...on alternative methods for chemical safety testing. , 2010, ALTEX.

[151]  David W Gaylor,et al.  Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? , 2005, Regulatory toxicology and pharmacology : RTP.

[152]  T. Braunbeck,et al.  Zebrafish teratogenicity test with metabolic activation (mDarT): effects of phase I activation of acetaminophen on zebrafish Danio rerio embryos. , 2010, Toxicology.

[153]  G. Colditz,et al.  Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. , 2012, Annual review of public health.

[154]  Thomas Hartung,et al.  Food for thought ... on alternative methods for cosmetics safety testing. , 2008, ALTEX.

[155]  J. Huff,et al.  Value of Historical Control Data and Other Issues Related to the Evaluation of Long-Term Rodent Carcinogenicity Studies , 1997, Toxicologic pathology.

[156]  Melvin E Andersen,et al.  Developing microphysiological systems for use as regulatory tools--challenges and opportunities. , 2014, ALTEX.

[157]  Mardas Daneshian,et al.  Animal use for science in Europe. , 2015, ALTEX.

[158]  Daniele Mandrioli,et al.  Evidence from Toxicology: The Most Essential Science for Prevention , 2015, Environmental health perspectives.

[159]  Robert J Kavlock,et al.  In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[160]  Thomas Hartung,et al.  Glossary of reference terms for alternative test methods and their validation. , 2014, ALTEX.

[161]  G. Ankley,et al.  Application of frog embryo teratogenesis assay‐Xenopus to ecological risk assessment , 2005, Environmental toxicology and chemistry.

[162]  V. Rogiers,et al.  Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective , 2015, Archives of Toxicology.

[163]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.

[164]  F. M. Johnson Response to Tennant et al.: Attempts to replace the NTP rodent bioassay with transgenic alternatives are unlikely to succeed , 2001 .

[165]  Michael Balls,et al.  Guidance on Good Cell Culture Practice , 2005, Alternatives to laboratory animals : ATLA.

[166]  D. Carlisle Air of danger. , 1990, Nursing Times.

[167]  Gerald T Ankley,et al.  Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[168]  Ali Khademhosseini,et al.  Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform , 2017, Scientific Reports.

[169]  T Hartung,et al.  The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development. , 2004, Current pharmaceutical design.

[170]  Nicole C. Kleinstreuer,et al.  Disruption of embryonic vascular development in predictive toxicology. , 2011, Birth defects research. Part C, Embryo today : reviews.

[171]  Daniel Morton,et al.  An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing , 2011, Toxicologic pathology.

[172]  Sebastian Hoffmann,et al.  The Emergence of Systematic Review in Toxicology , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[173]  Peter Kasper,et al.  Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties , 2016, Critical reviews in toxicology.

[174]  Martin Paparella,et al.  Uncertainty of testing methods--what do we (want to) know? , 2013, ALTEX.

[175]  Robert J Kavlock,et al.  Developmental toxicity testing for safety assessment: new approaches and technologies. , 2011, Birth defects research. Part B, Developmental and reproductive toxicology.

[176]  William Slikker Of human-on-a-chip and humans: Considerations for creating and using microphysiological systems , 2014, Experimental biology and medicine.

[177]  Karl-Heinz Krause,et al.  The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. , 2008, ALTEX.

[178]  Thomas Hartung,et al.  Systems Toxicology II: A Special Issue. , 2017, Chemical research in toxicology.

[179]  B. Aggarwal,et al.  Cancer is a Preventable Disease that Requires Major Lifestyle Changes , 2008, Pharmaceutical Research.

[180]  Aldert Piersma,et al.  A Review of the Implementation of the Embryonic Stem Cell Test (EST) , 2009, Alternatives to laboratory animals : ATLA.

[181]  L. Tanoue Cancer Statistics, 2009 , 2010 .

[182]  A. Colacci,et al.  Identification of pathway-based toxicity in the BALB/c 3T3 cell model. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[183]  Thomas B Knudsen,et al.  Systems Toxicology , 2015, International journal of toxicology.

[184]  J Glanville,et al.  Applicability and Feasibility of Systematic Review for Performing Evidence-Based Risk Assessment in Food and Feed Safety , 2015, Critical reviews in food science and nutrition.

[185]  B. van Ravenzwaay Initiatives to decrease redundancy in animal testing of pesticides. , 2010, ALTEX.

[186]  David Kirkland,et al.  A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. , 2011, Mutation research.

[187]  J. P. Van Oosterhout,et al.  The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe. , 1997, Regulatory toxicology and pharmacology : RTP.

[188]  G J Carr,et al.  Validation of alternative methods for toxicity testing. , 1998, Environmental health perspectives.

[189]  Alexandra Maertens,et al.  Integrated testing strategies for safety assessments. , 2013, ALTEX.

[190]  Thomas Hartung,et al.  A Modular Approach to the Extended One-generation Reproduction Toxicity Study , 2009, Alternatives to laboratory animals : ATLA.

[191]  I. Mangelsdorf,et al.  Relevance of non-guideline studies for risk assessment: the coverage model based on most frequent targets in repeated dose toxicity studies. , 2013, Toxicology letters.

[192]  Nancy Santesso,et al.  GRADE: Assessing the quality of evidence in environmental and occupational health. , 2016, Environment international.

[193]  Michael J Joyner,et al.  Ten questions about systems biology , 2011, The Journal of physiology.